Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00576
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 4, 2018
Authors
Publisher
Frontiers Media SA